Hypoproteinemia being a manifestation of immunotherapy-related liver dysfunction

Immunotherapy has changed the pattern of treatment in cancer. The interaction between programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibits the activation of T cells, and PD-1/PD-L1 inhibitors can increase the immune response to cancer cells by inducing the immune cells, which has...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Deng, Juan, Chen, Xiaoxia, Sun, Hui, Liu, Yu, Li, Wei, Chen, Bin, Zhao, Sha, Jia, Keyi, Wang, Hao, Guo, Haoyue, Jiang, Minlin, Xu, Yi, He, Yayi, Zhou, Caicun
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396795/
https://ncbi.nlm.nih.gov/pubmed/32793733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4980
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares